Question to the Department of Health and Social Care:

To ask His Majesty's Government what estimate they have made of the anticipated cost of weight loss drugs to the NHS in each of the next five years.

The Government does not hold an estimate for the anticipated cost of weight loss drugs to the National Health Service for this year or the next five years. Whilst there is data on total medicines budgets forecast up to 2028, in line with the Spending Review period, these budgets are not forecast down to the individual medicine level.

The Government does hold data on NHS spend on medicines used to treat obesity, including the newest medicines, GLP-1s. GLP-1s can be used to treat obesity or type 2 diabetes and it is not possible to separate data by usage. The data we hold is commercially confidential.